openPR Logo
Press release

Global Postmenopausal Osteoporosis Therapeutics Market to Incur Steady Growth During 2015-2021

10-18-2018 08:21 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Postmenopausal Osteoporosis Therapeutics Market

Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/5882

Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.

Based on the type of medicines used, postmenopausal osteoporosis therapeutics market is segmented as follows:

Bisphosphonates
Hormones
Strontium ranelate
Raloxifene
Denosumab
Others

Request TOC@ https://www.persistencemarketresearch.com/methodology/5882

Geographically, the global postmenopausal osteoporosis therapeutics market is segmented into:

North America
Europe
Asia Pacific
Rest of the World
Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Postmenopausal Osteoporosis Therapeutics Market to Incur Steady Growth During 2015-2021 here

News-ID: 1311775 • Views:

More Releases from Persistence Market Research

Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
The global smart door lock market is experiencing transformative growth as consumer demand for security, convenience, and smart home integration intensifies. The market size is projected to increase from US$ 3,059.7 Mn in 2025 to US$ 9,890.6 Mn by 2032, registering a robust CAGR of 18.3% during the forecast period. Rising concerns about home and workplace security, combined with rapid technological innovations, are fueling the adoption of smart door locks.
Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand in Flexible PVC Applications
Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand i …
The global Diisononyl Phthalate (DINP) market is undergoing a steady expansion, shaped by evolving industrial applications, regulatory dynamics, and technological innovations in plasticizers. As a key phthalate plasticizer, DINP is predominantly used in the production of flexible polyvinyl chloride (PVC) products. Its superior durability, flexibility, and resistance to weathering make it indispensable across a wide range of industries, from construction and automotive to consumer goods. According to the latest study by
Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand in Electronics and Battery Applications
Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand …
The global propylene carbonate market is entering a promising growth phase, fueled by rising demand across multiple industries, particularly in electronics, automotive, and paints & coatings. Propylene carbonate, a highly versatile organic compound, is widely recognized for its exceptional solvent properties, biodegradability, and low toxicity, making it a preferred choice in green chemistry applications. According to the latest study by Persistence Market Research, the market is expected to grow from US$275.5
Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
The Global Flexible Electronics Market is forecasted to expand at a CAGR of 11.4%, increasing from a value of US$ 2,762.0 million in 2023 to US$ 5,880.6 million by 2030. Flexible electronics is transforming the conventional electronics industry by integrating lightweight, bendable, and conformable devices into everyday life. These technologies are being widely adopted across consumer electronics, healthcare, automotive, and wearable technology sectors, promising increased portability, efficiency, and user-friendly designs. Elevate

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related